Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home About Us
In the News

August 21, 2014
Bioniche Life Sciences Announces Overnight Marketed Offering

August 19, 2014
Bioniche Announces Q1/2015 Timeline for the Filing of a Biologics License Application for Marketing Approval of MCNA in the United States


Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

About Us

Bioniche Life Sciences Inc. is a leading clinical stage biotechnology company focused on the development, manufacturing, and commercialization of proprietary and innovative therapeutics for the global human health market. The Company’s anchor product is in Phase III clinical development to treat non-muscle-invasive bladder cancer. The Company is exploring line extensions for its core technology and is actively seeking to add new and innovative development programs to its pipeline.

The Company is publicly traded on the Toronto Stock Exchange (TSX: BNC).

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy